Viewing Study NCT07257861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:05 PM
Ignite Modification Date: 2026-01-22 @ 9:51 PM
Study NCT ID: NCT07257861
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2025-09-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life
Sponsor: Centre Hospitalier Régional d'Orléans
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Parkinson Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Apomorphine View
None Parkinson View
None End of life View